Pooled platelet concentrates provide a small benefit over single-donor platelets for patients with platelet refractoriness of any etiology
Background At our institution, patients with platelet refractoriness (of any etiology) are sometimes switched from apheresis platelets to pooled platelets before human leukocyte antigen (HLA)-matched units become available. Study design and methods Seven patients were analyzed. Platelet counts were...
Main Authors: | Ying-Hsia Chu, William Nicholas Rose, William Nawrot, Thomas J. Raife |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211016748 |
Similar Items
-
Dose- and time-related platelet response with apheresis platelet concentrates and pooled platelets
by: Mohammad Mizanur Rahman, et al.
Published: (2017-02-01) -
Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
by: Jing-Cheng Zhang, et al.
Published: (2023-03-01) -
Effect of Platelet Additive Solution (PAS) on Random Donor Platelet Concentrates
by: Saira Bashir
Published: (2016-09-01) -
Buffy coat pooled platelet concentrate: A new age platelet component
by: Rakesh Kumar, et al.
Published: (2021-01-01) -
Platelet refractoriness
by: B Sunil Rajadhyaksha, et al.
Published: (2019-01-01)